Dexmedtomodine Effect on Agitated Psychotic Patients Suffer COPD

Active, not recruitingOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

June 10, 2024

Primary Completion Date

November 10, 2024

Study Completion Date

March 10, 2025

Conditions
Response of Agitated Patients to Dexmedetomidine
Interventions
DRUG

Dexmedetomidine

Effect o dexmedetomine on agitated normal and psychotic patients on BIPAP who are suffer exaggerated COPD

DEVICE

BIPAP

Put exaggerated COPD patients on non invasive ventillation

Trial Locations (1)

0020

Tanta, Tanta

All Listed Sponsors
collaborator

Laila Ahmed Abd-Elmotaleb El-Ahwal

UNKNOWN

collaborator

Marwa Ahmed Abogabal

UNKNOWN

lead

Tanta University

OTHER

NCT06567587 - Dexmedtomodine Effect on Agitated Psychotic Patients Suffer COPD | Biotech Hunter | Biotech Hunter